ASXC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ASXC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Asensus Surgical's Other Financing for the three months ended in Jun. 2024 was $15.00 Mil.
Asensus Surgical's Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 was $14.82 Mil.
The historical data trend for Asensus Surgical's Other Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asensus Surgical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Financing | Get a 7-Day Free Trial | 0.04 | 3.23 | 29.78 | - | -0.49 |
Asensus Surgical Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Other Financing | Get a 7-Day Free Trial | - | -0.01 | - | -0.17 | 15.00 |
Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges
Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Asensus Surgical's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Starling William N Jr | director | 2300 BUCKSKIN ROAD, POCATELLO ID 83201 |
Andrea Biffi | director | C/O SOFAR SPA, VIA FIRENZE 40, TREZZANO ROSA (MI) L6 20060 |
Elizabeth Kwo | director | C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803 |
David Bruce Milne | director | ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108 |
Kevin J Hobert | director | 343 STATE STREET, ROCHESTER NY 14650 |
Fernando Anthony C. J. | officer: Chief Technology Officer | 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560 |
Rampertab Shameze | officer: EVP, Chief Financial Officer | C/O ZOMEDICA PHARMACEUTICALS CORP., 3928 VARSITY DRIVE, ANN ARBOR MI 48108 |
Brett Farabaugh | officer: Interim CFO | 108 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709 |
Joseph P Slattery | officer: EVP and CFO | C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560 |
Eric A Smith | officer: Chief Commercial Officer | 7 CALEB CIRCLE, SAN ANTONIO TX 78258 |
Todd Pope | director, officer: President and CEO | C/O TRANSENTERIX, 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27713 |
Willam N Kelley | director | MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889 |
Pfenniger Richard C Jr | director | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Sofar, S.p.a | 10 percent owner | VIA FIRENZE 40, TREZZANO ROSA L6 20060 |
Andrew N Schiff | director, 10 percent owner | PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022 |
From GuruFocus
By GuruFocus Research • 08-14-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 03-22-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.